Literature DB >> 51142

Maternal effects of regular salicylate ingestion in pregnancy.

E Collins, G Turner.   

Abstract

6.6% of all Australian patients attending an antenatal clinic were found to be taking salicylate preparations regularly, most commonly in powder form and almost always as self-medication. In this group of salicylate takers there was an increased incidence of anaemia, anti-partum and post-partum haemorrhage, prolonged gestation, complicated deliveries, and perinatal mortality compared with non-takers. These findings suggest that regular salicylate consumption has detrimental effects in pregnancy. Routine antenatal urinary screening for salicylate in pregnancy is recommended.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51142     DOI: 10.1016/s0140-6736(75)92777-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  OTC drugs in pregnancy.

Authors:  J D Harper
Journal:  Can Fam Physician       Date:  1981-12       Impact factor: 3.275

2.  Aspirin use and chronic diseases.

Authors: 
Journal:  BMJ       Date:  1990-01-13

3.  Teratogenic risk of drugs used in early pregnancy.

Authors:  J Ruedy
Journal:  Can Fam Physician       Date:  1984-10       Impact factor: 3.275

4.  Drug therapy during pregnancy: implications for dental practice.

Authors:  A Ouanounou; D A Haas
Journal:  Br Dent J       Date:  2016-04-22       Impact factor: 1.626

Review 5.  Treatment of preterm labour. A review of the therapeutic options.

Authors:  S N Caritis
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

6.  Nonsteroidal anti-inflammatory agents in the primary treatment of rheumatoid arthritis.

Authors:  T P Anastassiades; I L Dwosh; P M Ford; G S Marks
Journal:  Can Med Assoc J       Date:  1979-10-20       Impact factor: 8.262

Review 7.  Initiation of parturition in humans.

Authors:  J W Drover; R F Casper
Journal:  Can Med Assoc J       Date:  1983-02-15       Impact factor: 8.262

8.  Effect of other drugs and chemicals on the degradation of aspirin in vitro: possible extrapolation to in vivo metabolism of aspirin.

Authors:  J D Gupta; M Gruca; W Ablett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

Review 9.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 10.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.